Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (584)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
161
2025
2998
11.360
Why?
Antibodies, Monoclonal
26
2024
462
6.240
Why?
Hematopoietic Stem Cell Transplantation
28
2024
578
3.390
Why?
Antineoplastic Agents
18
2024
1172
3.300
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1000
3.260
Why?
Humans
215
2025
50503
2.240
Why?
Thalidomide
24
2024
378
1.990
Why?
Monoclonal Gammopathy of Undetermined Significance
10
2024
112
1.880
Why?
Neoplasm Recurrence, Local
15
2024
629
1.800
Why?
Immunotherapy, Adoptive
9
2024
163
1.770
Why?
Killer Cells, Natural
8
2024
106
1.740
Why?
Transplantation, Autologous
26
2024
481
1.730
Why?
Interleukin-6
12
2023
261
1.660
Why?
Neoplasm Proteins
13
2022
320
1.580
Why?
Hematologic Neoplasms
3
2022
99
1.570
Why?
Middle Aged
76
2025
12611
1.510
Why?
Antigens, Neoplasm
6
2014
148
1.430
Why?
Clinical Trials as Topic
13
2022
486
1.410
Why?
Stem Cell Transplantation
10
2022
179
1.340
Why?
Aged
76
2025
9741
1.330
Why?
B-Cell Maturation Antigen
9
2025
99
1.320
Why?
Prognosis
45
2024
1978
1.300
Why?
Gene Expression Regulation, Neoplastic
20
2022
833
1.250
Why?
Combined Modality Therapy
19
2024
641
1.240
Why?
Chromosomes, Human, Pair 1
9
2023
92
1.230
Why?
Herpesvirus 8, Human
7
2021
97
1.190
Why?
Antibodies, Bispecific
6
2025
88
1.190
Why?
Translocation, Genetic
10
2022
240
1.170
Why?
Adult
56
2025
13577
1.160
Why?
Male
86
2025
25907
1.140
Why?
Female
88
2025
27081
1.120
Why?
Treatment Outcome
47
2024
5283
1.120
Why?
Boronic Acids
12
2013
183
1.100
Why?
Pyrazines
12
2013
188
1.100
Why?
Bone Marrow
18
2024
363
1.040
Why?
Proteasome Inhibitors
5
2024
104
1.030
Why?
Immunotherapy
6
2024
235
0.990
Why?
Gene Expression Profiling
26
2023
1025
0.980
Why?
Neoplasms, Second Primary
2
2024
74
0.970
Why?
Disease-Free Survival
24
2019
444
0.930
Why?
B-Lymphocytes
5
2024
171
0.910
Why?
Dexamethasone
14
2024
432
0.900
Why?
T-Lymphocytes, Cytotoxic
4
2014
63
0.880
Why?
Melphalan
9
2020
178
0.870
Why?
Cancer Vaccines
3
2010
80
0.860
Why?
Follow-Up Studies
26
2024
2242
0.840
Why?
Plasma Cells
11
2023
221
0.830
Why?
Hyperhidrosis
1
2022
2
0.820
Why?
Sweat
1
2022
7
0.810
Why?
Survival Rate
24
2020
909
0.790
Why?
Lymphoma, B-Cell
3
2022
49
0.790
Why?
Drug Approval
1
2022
47
0.780
Why?
Ehrlichia chaffeensis
1
2021
4
0.750
Why?
Patient Participation
1
2022
70
0.740
Why?
T-Lymphocytes
8
2024
325
0.740
Why?
Ehrlichiosis
1
2021
14
0.740
Why?
Cryosurgery
1
2021
36
0.730
Why?
Immunoglobulin Light Chains
3
2017
84
0.720
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
27
0.710
Why?
Embolization, Therapeutic
1
2021
88
0.690
Why?
Cell Proliferation
10
2023
985
0.680
Why?
Disease Progression
16
2023
829
0.670
Why?
Chromosomal Instability
1
2019
16
0.660
Why?
Membrane Proteins
3
2006
332
0.640
Why?
Neoplasms, Plasma Cell
3
2024
36
0.640
Why?
Survival Analysis
18
2024
661
0.630
Why?
Adrenal Cortex Hormones
2
2023
99
0.630
Why?
Immunologic Factors
2
2018
111
0.620
Why?
Neoplasm, Residual
8
2022
160
0.610
Why?
Epigenesis, Genetic
4
2023
372
0.610
Why?
Tumor Microenvironment
6
2024
222
0.600
Why?
Chromosome Aberrations
12
2023
280
0.600
Why?
Dendritic Cells
3
2014
135
0.590
Why?
POEMS Syndrome
1
2018
32
0.590
Why?
Atrial Fibrillation
2
2022
188
0.580
Why?
Thyroid Neoplasms
1
2019
112
0.570
Why?
Polymorphism, Single Nucleotide
3
2024
475
0.570
Why?
Prealbumin
2
2014
21
0.560
Why?
Antibodies, Monoclonal, Humanized
6
2023
226
0.550
Why?
Positron-Emission Tomography
7
2022
292
0.540
Why?
Receptors, Interleukin-6
2
2014
22
0.540
Why?
Aged, 80 and over
20
2025
3226
0.520
Why?
Cardiomyopathies
2
2014
120
0.510
Why?
Mutation
10
2022
1280
0.500
Why?
Osteolysis
4
2022
74
0.480
Why?
Immunotoxins
1
2014
6
0.460
Why?
Drug Resistance, Neoplasm
7
2024
316
0.460
Why?
Risk Factors
20
2025
3724
0.450
Why?
Recurrence
13
2024
659
0.450
Why?
Cytotoxicity, Immunologic
2
2012
55
0.450
Why?
Clonal Evolution
3
2020
56
0.440
Why?
Practice Guidelines as Topic
4
2023
468
0.440
Why?
Cyclophosphamide
5
2021
168
0.430
Why?
Transplantation, Homologous
5
2017
145
0.420
Why?
Amyloidosis
1
2014
81
0.420
Why?
Health Status
1
2015
299
0.420
Why?
Thrombocytopenia
3
2025
81
0.420
Why?
Fluorodeoxyglucose F18
6
2021
189
0.400
Why?
Genome-Wide Association Study
3
2024
163
0.400
Why?
Remission Induction
13
2021
208
0.390
Why?
Neutropenia
2
2023
116
0.390
Why?
Receptors, KIR
2
2008
13
0.380
Why?
Genetic Predisposition to Disease
3
2024
511
0.370
Why?
Bone Diseases
3
2021
96
0.370
Why?
Pyrimidines
2
2022
191
0.370
Why?
Dose-Response Relationship, Drug
8
2020
1372
0.370
Why?
Cytokines
3
2025
606
0.370
Why?
Azacitidine
1
2010
34
0.360
Why?
Benzamides
1
2010
50
0.360
Why?
Evolution, Molecular
2
2021
95
0.350
Why?
Histone Deacetylase Inhibitors
1
2010
56
0.350
Why?
C-Reactive Protein
6
2022
144
0.340
Why?
Prednisone
2
2021
101
0.340
Why?
Doxorubicin
6
2021
236
0.340
Why?
TOR Serine-Threonine Kinases
2
2020
78
0.330
Why?
Drug Administration Schedule
5
2015
370
0.330
Why?
Chromosome Deletion
5
2023
134
0.320
Why?
Metaphase
4
2016
45
0.320
Why?
Pelvis
2
2021
66
0.320
Why?
Vaccination
4
2022
280
0.320
Why?
Quality of Life
1
2015
851
0.320
Why?
Risk Assessment
10
2025
1270
0.320
Why?
Membrane Glycoproteins
2
2009
245
0.310
Why?
Lymph Nodes
4
2025
257
0.310
Why?
Animals
15
2024
13124
0.310
Why?
Paraproteinemias
3
2022
72
0.310
Why?
Disease Management
3
2025
178
0.300
Why?
Proportional Hazards Models
7
2024
415
0.300
Why?
Placebo Effect
2
2020
17
0.300
Why?
Young Adult
8
2025
4102
0.300
Why?
Fever
3
2025
112
0.290
Why?
Bone Neoplasms
4
2013
179
0.290
Why?
Adoptive Transfer
1
2007
30
0.290
Why?
Chromatin
3
2023
137
0.290
Why?
Histocompatibility Antigens Class I
1
2007
46
0.290
Why?
CD8-Positive T-Lymphocytes
3
2024
125
0.280
Why?
Cytogenetic Analysis
5
2023
74
0.280
Why?
DNA Methylation
4
2023
550
0.280
Why?
Registries
4
2025
563
0.280
Why?
Boron Compounds
2
2024
19
0.270
Why?
Chromans
2
2024
35
0.270
Why?
Vincristine
3
2021
82
0.270
Why?
Cell Membrane
1
2007
246
0.270
Why?
Mice, SCID
6
2013
178
0.270
Why?
Glycine
2
2024
78
0.260
Why?
Angiogenesis Inhibitors
5
2010
183
0.260
Why?
Down-Regulation
1
2007
340
0.260
Why?
In Situ Hybridization, Fluorescence
5
2023
231
0.260
Why?
Neoplasm Staging
6
2024
746
0.250
Why?
Cell Line, Tumor
9
2023
1398
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
34
0.250
Why?
Vitamin E
2
2024
78
0.250
Why?
Transplantation Conditioning
5
2008
87
0.250
Why?
Mice
11
2024
5687
0.250
Why?
Case-Control Studies
6
2024
1156
0.250
Why?
Infusions, Intravenous
3
2015
213
0.250
Why?
Bone Resorption
2
2022
302
0.240
Why?
Connective Tissue Diseases
1
2025
17
0.240
Why?
Antibody Formation
1
2005
50
0.240
Why?
Immunoglobulins, Intravenous
1
2025
65
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Autoantibodies
1
2025
117
0.230
Why?
Time Factors
11
2021
2935
0.230
Why?
Flow Cytometry
4
2012
474
0.230
Why?
Monocytes
2
2020
127
0.220
Why?
Gene Expression
2
2018
610
0.220
Why?
High-Throughput Nucleotide Sequencing
3
2022
169
0.220
Why?
Cell Cycle Proteins
2
2022
161
0.220
Why?
Ubiquitin-Protein Ligases
1
2024
95
0.220
Why?
Blotting, Western
3
2015
578
0.220
Why?
Proteasome Endopeptidase Complex
3
2011
116
0.210
Why?
Signal Transduction
6
2021
1624
0.210
Why?
Epstein-Barr Virus Infections
2
2020
30
0.210
Why?
Radiation-Protective Agents
1
2024
72
0.210
Why?
Integrin beta Chains
1
2023
13
0.210
Why?
Prospective Studies
8
2022
2378
0.210
Why?
Integrins
1
2023
30
0.210
Why?
Cross-Sectional Studies
3
2023
1610
0.210
Why?
Double-Blind Method
2
2015
708
0.210
Why?
Sweating
1
2022
7
0.200
Why?
Hematopoietic Stem Cells
2
2022
197
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.200
Why?
Consensus
2
2020
160
0.200
Why?
Kaplan-Meier Estimate
10
2016
464
0.200
Why?
DNA, Intergenic
1
2022
6
0.200
Why?
Tumor Cells, Cultured
4
2013
457
0.200
Why?
Proteomics
3
2021
314
0.200
Why?
Receptors, Antigen, T-Cell
1
2022
48
0.200
Why?
Tumor Suppressor Protein p53
2
2017
213
0.190
Why?
Immunoconjugates
1
2022
38
0.190
Why?
United States
4
2022
4955
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
United States Food and Drug Administration
1
2022
90
0.190
Why?
Influenza, Human
1
2022
86
0.190
Why?
Chromosomes, Human, Pair 14
3
2020
66
0.190
Why?
Mediastinum
1
2021
21
0.190
Why?
Epigenomics
1
2021
68
0.190
Why?
Receptors, Glucocorticoid
2
2012
32
0.190
Why?
Phosphatidylinositol 3-Kinases
2
2019
140
0.190
Why?
Ubiquitination
1
2021
42
0.190
Why?
Apoptosis
5
2018
1097
0.180
Why?
Axilla
1
2021
91
0.180
Why?
Retrospective Studies
10
2025
6263
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
81
0.180
Why?
Alleles
3
2021
256
0.180
Why?
Multiple Organ Failure
1
2021
48
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
90
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Adolescent
7
2025
6443
0.180
Why?
Salvage Therapy
6
2013
137
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
125
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.180
Why?
Rare Diseases
1
2020
43
0.180
Why?
Interferon-gamma
3
2014
177
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Radiopharmaceuticals
4
2021
204
0.170
Why?
Cell Cycle
1
2021
226
0.170
Why?
Longitudinal Studies
5
2024
735
0.170
Why?
Myelodysplastic Syndromes
2
2013
78
0.170
Why?
Interferon Type I
1
2020
24
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
32
0.170
Why?
Research Design
2
2020
353
0.170
Why?
Multivariate Analysis
8
2021
583
0.170
Why?
Gene Amplification
1
2019
56
0.170
Why?
Genomics
4
2023
279
0.170
Why?
Measles virus
1
2019
8
0.160
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
DNA
1
2023
535
0.160
Why?
Measles
1
2019
7
0.160
Why?
Data Collection
1
2020
280
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Health Status Disparities
1
2022
202
0.160
Why?
Immunohistochemistry
2
2015
957
0.160
Why?
Oncolytic Virotherapy
1
2019
18
0.160
Why?
Biopsy
5
2018
588
0.160
Why?
Patient Safety
1
2020
102
0.160
Why?
Sirolimus
1
2019
62
0.160
Why?
Cell Differentiation
6
2022
640
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
281
0.160
Why?
Precancerous Conditions
2
2010
82
0.160
Why?
Proto-Oncogene Proteins c-akt
1
2019
156
0.160
Why?
Evidence-Based Medicine
2
2018
253
0.160
Why?
Syndrome
1
2019
240
0.150
Why?
Graft vs Host Disease
4
2007
84
0.150
Why?
MafB Transcription Factor
1
2018
9
0.150
Why?
Spleen
1
2019
169
0.150
Why?
Genomic Instability
2
2016
90
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Immunomodulation
1
2018
36
0.150
Why?
Chemokines
1
2018
75
0.150
Why?
Plasma
1
2018
46
0.150
Why?
Myeloablative Agonists
2
2008
32
0.150
Why?
Hematopoietic Stem Cell Mobilization
2
2008
58
0.150
Why?
Genes, Neoplasm
2
2015
27
0.150
Why?
Osteoclasts
3
2022
427
0.140
Why?
Models, Biological
2
2018
716
0.140
Why?
Adipocytes
1
2018
126
0.140
Why?
Magnetic Resonance Imaging
5
2013
1548
0.140
Why?
Gene Dosage
2
2015
74
0.140
Why?
Gene Rearrangement
1
2018
65
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Communication
1
2019
250
0.140
Why?
Heterozygote
2
2014
83
0.140
Why?
HLA-A Antigens
2
2007
10
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Protein-Tyrosine Kinases
2
2018
88
0.140
Why?
Drug Therapy, Combination
1
2018
384
0.140
Why?
Oligonucleotide Array Sequence Analysis
5
2010
405
0.130
Why?
Gene Frequency
2
2013
97
0.130
Why?
Transcriptome
4
2020
313
0.130
Why?
Syndecan-1
4
2021
75
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.130
Why?
Lymphocyte Activation
2
2017
164
0.130
Why?
Critical Illness
1
2018
302
0.130
Why?
Confidence Intervals
2
2014
154
0.130
Why?
Tumor Burden
3
2020
130
0.130
Why?
Immunity, Innate
1
2016
105
0.130
Why?
Erythrocyte Indices
1
2015
7
0.120
Why?
Biomarkers, Pharmacological
2
2012
25
0.120
Why?
DNA Copy Number Variations
3
2022
109
0.120
Why?
Coculture Techniques
2
2013
142
0.120
Why?
Hemoglobins
2
2013
109
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.120
Why?
Hematologic Diseases
1
2014
21
0.120
Why?
Half-Life
1
2014
86
0.120
Why?
International Cooperation
1
2014
47
0.110
Why?
Fatigue
1
2015
127
0.110
Why?
Iron
1
2015
121
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.110
Why?
Area Under Curve
1
2014
179
0.110
Why?
Antibodies
2
2024
153
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Reference Values
1
2014
307
0.110
Why?
ROC Curve
1
2014
226
0.110
Why?
Severity of Illness Index
2
2014
978
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
73
0.110
Why?
Emotions
1
2015
168
0.110
Why?
Disease Models, Animal
2
2016
1436
0.110
Why?
Renal Insufficiency
2
2021
110
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Inflammation Mediators
1
2014
111
0.110
Why?
Cisplatin
4
2013
286
0.110
Why?
Macaca mulatta
2
2024
97
0.110
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.110
Why?
Central Nervous System Neoplasms
1
2013
63
0.100
Why?
beta Catenin
1
2013
97
0.100
Why?
Venous Thrombosis
2
2004
87
0.100
Why?
Oligopeptides
1
2013
95
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
65
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Edema
2
2025
69
0.100
Why?
Mental Health
1
2015
228
0.100
Why?
Cell Survival
2
2020
589
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
70
0.100
Why?
Maintenance Chemotherapy
1
2012
48
0.100
Why?
Pain
1
2015
387
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
182
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
198
0.100
Why?
Models, Genetic
2
2016
172
0.100
Why?
Interleukin-2
1
2012
71
0.100
Why?
Cell Movement
1
2013
247
0.100
Why?
Mice, Inbred NOD
1
2012
91
0.100
Why?
Immunoenzyme Techniques
1
2012
137
0.100
Why?
Hemangioma
1
2013
83
0.100
Why?
Soft Tissue Neoplasms
1
2012
54
0.090
Why?
Genotype
1
2013
533
0.090
Why?
Immunoglobulin G
2
2025
190
0.090
Why?
Arkansas
5
2021
1985
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
46
0.090
Why?
Chemokine CXCL13
2
2022
5
0.090
Why?
Models, Statistical
2
2014
226
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
56
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
CD40 Ligand
1
2010
14
0.090
Why?
Hypersensitivity, Delayed
1
2010
19
0.090
Why?
Secondary Prevention
1
2010
79
0.090
Why?
Interleukin-4
1
2010
42
0.090
Why?
Up-Regulation
4
2018
446
0.090
Why?
HIV Seropositivity
1
2010
26
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
15
0.090
Why?
Immunity, Cellular
1
2010
63
0.090
Why?
Adjuvants, Immunologic
1
2010
51
0.090
Why?
Cell Line
2
2013
988
0.090
Why?
Cells, Cultured
3
2013
1571
0.080
Why?
Ovarian Neoplasms
1
2014
450
0.080
Why?
Etoposide
2
2007
77
0.080
Why?
Placenta
1
2011
134
0.080
Why?
Transplantation, Heterologous
1
2009
75
0.080
Why?
Radiography
4
2012
485
0.080
Why?
Histones
2
2021
297
0.080
Why?
Hospitalization
2
2024
675
0.080
Why?
Polymerase Chain Reaction
1
2010
449
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
27
0.080
Why?
Transcription Factors
2
2023
565
0.080
Why?
Bone and Bones
3
2021
478
0.080
Why?
Lymphocyte Subsets
1
2008
14
0.080
Why?
Liver Neoplasms
1
2012
326
0.080
Why?
Haplotypes
1
2008
84
0.080
Why?
Immunoglobulin lambda-Chains
1
2008
14
0.080
Why?
Granulocyte Colony-Stimulating Factor
1
2008
63
0.080
Why?
Cytogenetics
1
2008
21
0.080
Why?
Gene Deletion
1
2009
261
0.080
Why?
Neoplastic Stem Cells
1
2009
98
0.070
Why?
Receptors, Immunologic
1
2008
35
0.070
Why?
Ligands
1
2008
203
0.070
Why?
Osteogenesis
1
2011
356
0.070
Why?
Twins
1
2007
20
0.070
Why?
Busulfan
1
2007
19
0.070
Why?
Diphosphonates
1
2008
90
0.070
Why?
Herpesviridae Infections
2
2019
54
0.070
Why?
Immunophenotyping
1
2007
105
0.070
Why?
Leukocytes, Mononuclear
1
2007
118
0.070
Why?
Caspases
2
2018
103
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Creatinine
1
2007
145
0.070
Why?
Skin Neoplasms
1
2012
491
0.070
Why?
Blood Proteins
1
2007
84
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Immunosuppressive Agents
1
2008
225
0.070
Why?
Graft vs Leukemia Effect
1
2006
3
0.070
Why?
Chromosome Banding
1
2006
18
0.070
Why?
Plasmacytoma
1
2006
42
0.070
Why?
Cohort Studies
3
2020
1452
0.070
Why?
MicroRNAs
1
2010
344
0.070
Why?
Amiloride
1
2005
8
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Bone Marrow Transplantation
2
2022
136
0.060
Why?
Imaging, Three-Dimensional
2
2017
150
0.060
Why?
Child
3
2025
6906
0.060
Why?
Sensitivity and Specificity
1
2007
859
0.060
Why?
Japan
1
2025
27
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
29
0.060
Why?
Predictive Value of Tests
3
2018
930
0.060
Why?
Tomography, X-Ray Computed
2
2023
1164
0.060
Why?
Autoantigens
1
2025
48
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
4
0.060
Why?
Piperidones
1
2024
7
0.060
Why?
Enoxaparin
1
2004
31
0.060
Why?
Telomere
1
2024
35
0.060
Why?
Retreatment
1
2024
56
0.060
Why?
NF-kappa B
2
2018
315
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Morpholines
1
2024
66
0.060
Why?
Cost of Illness
1
2024
114
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
79
0.060
Why?
Neoplasms
1
2014
1251
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
49
0.050
Why?
Fibroblasts
1
2005
336
0.050
Why?
Epidemiologic Methods
3
2008
46
0.050
Why?
DNA, Neoplasm
2
2020
143
0.050
Why?
Gene Silencing
2
2016
115
0.050
Why?
Cluster Analysis
3
2010
219
0.050
Why?
Cell Communication
1
2023
68
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
48
0.050
Why?
Geography
1
2022
60
0.050
Why?
Phenotype
1
2025
739
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Whole-Body Irradiation
1
2022
132
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Quantitative Trait Loci
1
2022
42
0.050
Why?
Primary Cell Culture
1
2022
60
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
Risk
2
2014
324
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Anticoagulants
1
2004
256
0.050
Why?
Phylogeny
1
2022
236
0.050
Why?
Age of Onset
2
2013
108
0.050
Why?
Child, Preschool
2
2020
3942
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Rabbits
2
2013
372
0.050
Why?
RANK Ligand
1
2022
187
0.050
Why?
Polymorphism, Genetic
1
2022
180
0.050
Why?
Transcriptional Activation
1
2021
119
0.050
Why?
Fibrosis
1
2021
181
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Base Sequence
1
2022
639
0.040
Why?
Spatio-Temporal Analysis
1
2020
9
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Repressor Proteins
1
2022
148
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Genome, Human
1
2021
109
0.040
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Genetic Loci
1
2020
45
0.040
Why?
Mice, Transgenic
1
2021
540
0.040
Why?
False Negative Reactions
1
2019
29
0.040
Why?
Genetic Variation
1
2020
207
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
Neoplasm Invasiveness
1
2020
269
0.040
Why?
Incidence
2
2013
1032
0.040
Why?
Europe
1
2019
79
0.040
Why?
Herpesvirus 4, Human
1
2019
37
0.040
Why?
Communicable Disease Control
1
2019
35
0.040
Why?
RNA, Messenger
2
2016
1089
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
Computational Biology
1
2020
215
0.040
Why?
Genome, Viral
1
2019
79
0.040
Why?
Virus Diseases
1
2019
42
0.040
Why?
DNA, Viral
1
2019
136
0.040
Why?
Fibrinogen
1
2018
32
0.040
Why?
Immunoglobulin A
1
2018
44
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
20
0.040
Why?
Bone Marrow Cells
2
2014
196
0.040
Why?
Platelet Count
2
2008
65
0.040
Why?
DNA-Binding Proteins
1
2021
418
0.040
Why?
Pathology, Molecular
1
2018
22
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
Why?
Oncogene Proteins, Fusion
1
2018
57
0.040
Why?
Data Interpretation, Statistical
2
2010
162
0.040
Why?
Databases, Factual
2
2013
673
0.040
Why?
Kidney Function Tests
1
2017
51
0.040
Why?
False Positive Reactions
1
2017
59
0.030
Why?
Glomerular Filtration Rate
1
2017
119
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
181
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
19
0.030
Why?
Internationality
1
2017
41
0.030
Why?
Amino Acid Sequence
1
2018
574
0.030
Why?
Alkaline Phosphatase
1
2017
93
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
76
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
Glycolysis
1
2016
69
0.030
Why?
Proteolysis
1
2016
96
0.030
Why?
Enzyme Activation
1
2016
268
0.030
Why?
Chromosome Mapping
2
2006
153
0.030
Why?
Prevalence
1
2019
971
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Phosphorylation
1
2016
525
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Myocardium
1
2017
445
0.030
Why?
Asymptomatic Diseases
1
2014
37
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
54
0.030
Why?
Homozygote
1
2013
57
0.030
Why?
Cerebrospinal Fluid
1
2013
32
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Diagnosis, Differential
1
2017
1033
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
7
0.030
Why?
Receptors, CXCR4
1
2013
30
0.030
Why?
Dependovirus
1
2014
102
0.030
Why?
Niacinamide
1
2013
23
0.030
Why?
Amides
1
2013
35
0.030
Why?
NAD
1
2013
41
0.030
Why?
Enzyme Induction
1
2013
79
0.030
Why?
Nitriles
1
2013
52
0.030
Why?
Sirtuin 1
1
2013
28
0.030
Why?
Chemokine CXCL12
1
2013
33
0.030
Why?
Gene Knockdown Techniques
1
2013
105
0.030
Why?
Transplantation Chimera
2
2003
14
0.030
Why?
RNA, Small Interfering
1
2013
208
0.030
Why?
Infant
1
2020
3628
0.020
Why?
Piperidines
1
2013
99
0.020
Why?
Induction Chemotherapy
1
2012
59
0.020
Why?
Lymphocyte Count
1
2011
19
0.020
Why?
HIV Infections
1
2016
352
0.020
Why?
Acute Disease
1
2013
373
0.020
Why?
Chemokine CXCL10
1
2011
19
0.020
Why?
Antibodies, Neutralizing
1
2011
62
0.020
Why?
Sex Factors
1
2013
712
0.020
Why?
Pharmacogenetics
1
2011
50
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
25
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
45
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
45
0.020
Why?
Enzyme Inhibitors
1
2013
377
0.020
Why?
Microarray Analysis
1
2010
70
0.020
Why?
International Classification of Diseases
1
2010
63
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
RNA-Binding Proteins
1
2011
118
0.020
Why?
Oligonucleotides
1
2010
80
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
60
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Neoplasm Metastasis
1
2009
232
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
34
0.020
Why?
Polyethylene Glycols
1
2008
86
0.020
Why?
Serum Albumin
1
2008
57
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
573
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
212
0.020
Why?
Age Distribution
1
2007
170
0.020
Why?
Recombinant Proteins
1
2008
476
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
43
0.020
Why?
Proteoglycans
1
2006
83
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
181
0.020
Why?
Brain
1
2013
1319
0.020
Why?
Survivors
1
2006
128
0.020
Why?
Pregnancy
1
2011
2452
0.010
Why?
Probability
1
2003
164
0.010
Why?
Lymphocyte Transfusion
1
2003
12
0.010
Why?
Administration, Oral
1
2003
434
0.010
Why?
Tissue Donors
1
2003
121
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description